ABCL – AbCellera Biologics Inc.
Name : AbCellera Biologics Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $0.0000
EPSttm :
[iframe https://s.tradingview.com/embed-widget/symbol-info/?locale=in&symbol=ABCL
#%7B%22symbol%22%3A%22A%22%2C%22width%22%3A%22100%25%22%2C%22colorTheme%22%3A%22light%22%2C%22isTransparent%22%3Atrue%2C%22height%22%3A203%2C%22utm_source%22%3A%22themarketstracker.com%22%2C%22utm_medium%22%3A%22widget_new%22%2C%22utm_campaign%22%3A%22symbol-info%22%7D 900 250 ]
[iframe https://api.stockdio.com/visualization/financial/charts/v1/PricesChange?app-key=F086EEE750E14D8D8A456DB88B2D6D8C&symbol=ABCL
&conditionalVolume=false&allowPeriodChange=false&tooltipsStyle=None&palette=Financial-Light&showBorderAndTitle=false 300 200 ]
Float Short %
15.95
Margin Of Safety %
Put/Call OI Ratio
0.18
EPS Next Q Diff
-0.01
EPS Last/This Y
-0.11
EPS This/Next Y
0.1
Price
4.24
Target Price
9.17
Analyst Recom
1.25
Performance Q
70.28
Relative Volume
1.08
Beta
0.65
Ticker: ABCL
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-07-04 | ABCL | 3.82 | 0.15 | 0.40 | 47724 |
| 2025-07-07 | ABCL | 4.02 | 0.16 | 0.20 | 47836 |
| 2025-07-08 | ABCL | 3.89 | 0.16 | 0.25 | 47870 |
| 2025-07-09 | ABCL | 4.22 | 0.16 | 0.16 | 48464 |
| 2025-07-10 | ABCL | 4.24 | 0.17 | 0.26 | 50704 |
| 2025-07-11 | ABCL | 4 | 0.18 | 0.15 | 51825 |
| 2025-07-14 | ABCL | 4.23 | 0.19 | 0.06 | 52243 |
| 2025-07-15 | ABCL | 3.92 | 0.19 | 0.16 | 52339 |
| 2025-07-16 | ABCL | 4.05 | 0.19 | 0.06 | 55111 |
| 2025-07-17 | ABCL | 3.89 | 0.18 | 0.27 | 56443 |
| 2025-07-18 | ABCL | 4.47 | 0.19 | 0.04 | 57157 |
| 2025-07-21 | ABCL | 5.14 | 0.15 | 0.13 | 43946 |
| 2025-07-22 | ABCL | 4.91 | 0.16 | 0.08 | 53174 |
| 2025-07-23 | ABCL | 4.99 | 0.16 | 0.18 | 54212 |
| 2025-07-24 | ABCL | 5.01 | 0.16 | 0.05 | 55809 |
| 2025-07-25 | ABCL | 5.11 | 0.17 | 0.28 | 55679 |
| 2025-07-28 | ABCL | 4.91 | 0.17 | 0.18 | 57432 |
| 2025-07-29 | ABCL | 4.68 | 0.18 | 0.10 | 58273 |
| 2025-07-30 | ABCL | 4.57 | 0.17 | 0.09 | 61183 |
| 2025-07-31 | ABCL | 4.57 | 0.17 | 0.11 | 61611 |
| 2025-08-01 | ABCL | 4.24 | 0.18 | 0.15 | 62096 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-07-04 | ABCL | 3.80 | -21.8 | - | -0.65 |
| 2025-07-07 | ABCL | 4.02 | -21.8 | - | -0.65 |
| 2025-07-08 | ABCL | 3.89 | -21.8 | - | -0.65 |
| 2025-07-09 | ABCL | 4.22 | -21.8 | - | -0.65 |
| 2025-07-10 | ABCL | 4.25 | -21.8 | - | -0.65 |
| 2025-07-11 | ABCL | 4.01 | -21.8 | - | -0.65 |
| 2025-07-14 | ABCL | 4.24 | -21.8 | - | -0.65 |
| 2025-07-15 | ABCL | 3.94 | -21.8 | - | -0.65 |
| 2025-07-16 | ABCL | 4.05 | -21.8 | - | -0.65 |
| 2025-07-17 | ABCL | 3.90 | -21.8 | - | -0.65 |
| 2025-07-18 | ABCL | 4.47 | -21.8 | - | -0.65 |
| 2025-07-21 | ABCL | 5.14 | -21.8 | - | -0.65 |
| 2025-07-22 | ABCL | 4.92 | -21.8 | - | -0.65 |
| 2025-07-23 | ABCL | 4.99 | -21.8 | - | -0.65 |
| 2025-07-24 | ABCL | 5.02 | -21.8 | - | -0.65 |
| 2025-07-25 | ABCL | 5.11 | -21.8 | - | -0.65 |
| 2025-07-28 | ABCL | 4.91 | -21.8 | - | -0.65 |
| 2025-07-29 | ABCL | 4.69 | -23.1 | - | -0.65 |
| 2025-07-30 | ABCL | 4.57 | -23.1 | - | -0.65 |
| 2025-07-31 | ABCL | 4.47 | -25.6 | - | -0.65 |
| 2025-08-01 | ABCL | 4.24 | -25.6 | - | -0.66 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-07-04 | ABCL | 0.00 | 12.81 | 11.84 |
| 2025-07-07 | ABCL | 0.00 | 13.05 | 11.84 |
| 2025-07-08 | ABCL | 0.00 | 13.05 | 11.84 |
| 2025-07-09 | ABCL | 0.00 | 13.05 | 11.84 |
| 2025-07-10 | ABCL | 0.00 | 13.05 | 11.84 |
| 2025-07-11 | ABCL | 0.00 | 13.05 | 13.58 |
| 2025-07-14 | ABCL | 0.00 | 12.97 | 13.58 |
| 2025-07-15 | ABCL | 0.00 | 12.97 | 13.58 |
| 2025-07-16 | ABCL | 0.00 | 12.97 | 13.58 |
| 2025-07-17 | ABCL | 0.00 | 12.97 | 13.58 |
| 2025-07-18 | ABCL | 0.00 | 12.97 | 13.58 |
| 2025-07-21 | ABCL | 0.00 | 12.96 | 13.58 |
| 2025-07-22 | ABCL | 0.00 | 12.96 | 13.58 |
| 2025-07-23 | ABCL | 0.00 | 12.96 | 13.58 |
| 2025-07-24 | ABCL | 0.00 | 12.96 | 13.58 |
| 2025-07-25 | ABCL | 0.00 | 12.96 | 15.95 |
| 2025-07-28 | ABCL | 0.00 | 13.40 | 15.95 |
| 2025-07-29 | ABCL | 0.00 | 13.40 | 15.95 |
| 2025-07-30 | ABCL | 0.00 | 13.40 | 15.95 |
| 2025-07-31 | ABCL | 0.00 | 13.40 | 15.95 |
| 2025-08-01 | ABCL | 0.00 | 13.40 | 15.95 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
[iframe https://widget.finnhub.io/widgets/historical-eps?symbol=ABCL
589 360 ]
Last Quarter Act. EPS
-0.15
Avg. EPS Est. Current Quarter
-0.16
Avg. EPS Est. Next Quarter
-0.16
Insider Transactions
Institutional Transactions
13.4
Beta
0.65
Average Sales Estimate Current Quarter
7
Average Sales Estimate Next Quarter
6
Fair Value
Quality Score
22
Growth Score
31
Sentiment Score
23
Actual DrawDown %
94.1
Max Drawdown 5-Year %
Target Price
9.17
P/E
Forward P/E
PEG
P/S
54.74
P/B
1.24
P/Free Cash Flow
EPS
-0.57
Average EPS Est. Cur. Y
-0.66
EPS Next Y. (Est.)
-0.56
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-726.23
Relative Volume
1.08
Return on Equity vs Sector %
-40.1
Return on Equity vs Industry %
-21.5
EPS 1 7Days Diff
EPS 1 30Days Diff
-0.01
EBIT Estimation
[iframe https://widget.finnhub.io/widgets/recommendation?symbol=ABCL
589 450 ]
[iframe https://widget.finnhub.io/widgets/eps-estimate?symbol=ABCL
589 450 ]
AbCellera Biologics Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 596
AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its product pipeline includes ABCL635, an antibody-drug candidate, which is in preclinical trial to treat metabolic and endocrine conditions; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in preclinical trial for treating T-cell-mediated autoimmune conditions, such as atopic dermatitis. The company has a research collaboration and license agreement with Eli Lilly and Company; and partnership agreement with Viking Global Investors & ArrowMark Partners and Biogen Inc. AbCellera Biologics Inc. was incorporated in 2012 and is headquartered in Vancouver, Canada.
stock quote shares ABCL – AbCellera Biologics Inc. Stock Price stock today
news today ABCL – AbCellera Biologics Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch ABCL – AbCellera Biologics Inc. yahoo finance google finance
stock history ABCL – AbCellera Biologics Inc. invest stock market
stock prices ABCL
premarket after hours
ticker ABCL
fair value insiders trading